SCHEDULE 13G/A: BlackRock Amends Passive Stake in Baxter International, Discloses 7.5% Ownership

BlackRock, Inc. has filed an Amendment No. 11 to its Schedule 13G, reporting a 7.5% passive beneficial ownership stake in Baxter International Inc. as of March 31, 2025.

Summary

• BlackRock, Inc. reported beneficial ownership of 38,621,365 shares of Baxter International Inc. common stock.
• This ownership represents 7.5% of Baxter International Inc.'s outstanding common stock.
• BlackRock, Inc. holds sole voting power over 34,743,616 shares and sole dispositive power over 38,621,365 shares.
• The filing indicates that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
• The filing is an Amendment No. 11 to a previously filed Schedule 13G, indicating an ongoing passive investment by BlackRock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing disclosing passive ownership. It contains factual information about BlackRock's stake in Baxter International Inc. and does not inherently convey positive or negative sentiment about the issuer's performance or prospects.

Positives

• The disclosure of a significant passive stake by a major institutional investor like BlackRock indicates continued institutional interest and confidence in Baxter International Inc.
• BlackRock's certification states the shares are held in the ordinary course of business, implying a long-term, non-activist investment approach.

Negatives

• The Schedule 13G filing itself does not contain any negative information regarding Baxter International Inc.'s operations or financial performance, as it is solely an ownership disclosure.

Risks

• The document does not detail specific risks related to Baxter International Inc.'s business operations or financial health, as it is an ownership disclosure filing.

Future Outlook

This Schedule 13G filing does not provide any forward-looking statements or guidance regarding Baxter International Inc.'s future performance or outlook.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

BlackRock, as one of the world's largest asset managers, routinely holds significant passive stakes in publicly traded companies across various sectors, including healthcare. Its 7.5% stake in Baxter International Inc., a global medical products company, is consistent with typical institutional portfolio diversification strategies.

Corporate Governance

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's passive stake, which can be viewed as a vote of confidence in the company's long-term stability.

Next Steps

• BlackRock, Inc. will continue to monitor its investment in Baxter International Inc. and file further amendments to its Schedule 13G if its beneficial ownership percentage changes significantly or if its investment intent shifts from passive to active.

Key Dates

Keywords

BlackRock, Baxter International, Schedule 13G, SEC filing, beneficial ownership, institutional investor, common stock, passive investment, healthcare, medical products